TwoStep Therapeutics
Targeted Cancer Therapies
1 open roleTargeted Cancer TherapiesSan Carlos, United States7 employees$21M raisedEst. 2024
NFX
2048 Ventures
Alexandria Venture Investments
Cooley's affiliated fund GC&H Investments
Family office of the founder of Arcadia Investment Partners
About TwoStep Therapeutics
- TwoStep Therapeutics is a biotechnology company developing innovative, first-in-class, multispecific targeted peptide conjugate therapies for solid tumors.
- The pipeline is built around a versatile targeting peptide “PIP” that binds selectively to multiple tumor.
TwoStep Therapeutics is listed on Rocketlist with 1 active role. The company is categorized as Targeted Cancer Therapies in BioTech. TwoStep Therapeutics is at Series A stage, with a B2B business model, headquartered in San Carlos, United States. TwoStep Therapeutics was founded in 2024 and has 7 employees. TwoStep Therapeutics has raised $21M. Active roles are refreshed daily from public hiring sources.